The HCPLive uveitis page is a comprehensive resource for clinical news and insights on chorioretinitis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for eye inflammation, and more.

Latest News

Se Joon Woo, MD, PhD | Image Credit: Seoul National University College of Medicine
Switch to Adalimumab Biosimilar Shows No Significant Differences for Uveitis

January 21st 2024

Patients with uveitis switched from adalimumab originator to SB5 did not experience clinically significant differences in treatment efficacy and safety.

Eye | Image Credit: Vanessa Bumbeers/Unsplash
TNF-Inhibitor Biosimilars Prove Effective, Safe in Pediatric Non-infectious Uveitis

January 19th 2024

Timothy Janetos, MD, MBA | Image Credit: Northwestern Medicine
0.18 Mg Fluocinolone Acetonide Implant, Corticosteroid Burst Useful Adjuvant for Uveitis

January 14th 2024

Tahreen A. Mir, MD | Image Credit: Vanderbilt University Medical Center
National Incidence of Syphilitic Uveitis Grew in the US Over a 10-Year Period

December 24th 2023

XEN-45 Implant Treats Patients with Uncontrolled Uveitic Glaucoma
XEN-45 Implant Shows Promise for Treating Patients with Uncontrolled Uveitic Glaucoma

December 7th 2023

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.